
    
      This two-arm, multicentre, randomized, placebo-controlled, double-blind, parallel-design
      study consisted of a baseline phase (screening and wash-out) and a double-blind randomized
      phase (randomization to Trazodone ContramidÂ® OAD or placebo). The total study duration
      including wash-out of prohibited medications was approximately 11 weeks; the total duration
      of the randomized phase was 8 weeks (titration: 2 weeks + treatment: 6 weeks).
    
  